Diet Doc Patients Thought to Lose More Weight Than Contrave

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Diet Doc Patients Thought to Lose More Weight Than Contrave or Belviq Patients Without Dangerous Prescription Drug Side Effects

NEW YORK, Jan. 23, 2015 (GLOBE NEWSWIRE) -- Internet reports claiming that the Endocrine Society is now recommending prescription drugs to accompany diet plans for obese patients offer two drug manufacturing companies the potential for immense financial gain. Like most drugs, Contrave and Belviq list a host of potential prescription drug side effects that should not be ignored.

Among a long list of potential prescription drug side effects, Contrave and Belviq warning labels caution patients to be aware of suicidal thoughts while encouraging emergency medical attention for a number of symptoms, including increased blood pressure or heart rate, swelling of the lips or tongue, stomach pain or tiredness. Contrave patients are also advised of potential liver damage and manic episodes.

Belviq, thought to promote weight loss by affecting the appetite chemicals in the brain, is used in conjunction with diet plans and exercise. Patients are encouraged to alert their doctor if they have not lost at least 5% of their starting body weight after 12 weeks and are warned about Belviq's habit forming potential.

Because of the nation's very real obesity epidemic, pharmaceutical companies throughout the country are interested in learning more about the intricacies of appetite and hunger. Research has revealed that the same hormones and neurotransmitters that affect hunger and appetite also control one's mood and emotions. This is one of the most formidable challenges for pharmaceutical companies when developing drugs for weight loss because most drugs designed to control appetite and hunger tend to have potential side effects similar to drugs used to treat depression, anxiety, addiction and seizures.

While there is still much to learn about appetite and hunger, the ultimate answer may lie in balancing the existing system of hormones and neurotransmitters. Ensuring that all hormones and neurotransmitters are in balance keeps appetite and hunger harmonious to the body's energy requirements. 

Diet Doc's medical diet plans aim to balance the system, rather than control it with drugs. Their diet plans combine healthy, low-carbohydrate foods with prescription hormone diet treatments, appetite suppressants and proprietary diet pills to balance hormones, control appetite and overcome the urge to indulge in high carbohydrate foods. New patients can log onto the internet to complete a health questionnaire and schedule an online consult with a Diet Doc physician. During the consult, the doctor will review the entire system to uncover the real reason for weight gain, such as hormonal imbalances, improperly functioning organs or cellular toxicity. 

Patients that follow Diet Doc's medical diet plans report rapid weight loss without side effects, while Contrave's clinical trials reported an average loss of only 7.5 pounds per year and include a long list of potential prescription drug side effects.

Providing care across the USA Headquarters: San Diego, CA (888) 934-4451 http://www.dietdoc.com Twitter: https://twitter.com/DietDocMedical Facebook: DietDocMedicalWeightLoss

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Challenges in Glencore-Rio Tinto Merger Talks Unfolding

Updated Category News Views 252

Challenges in Glencore-Rio Tinto Merger Talks Unfolding Recent developments have surfaced regarding the potential merger between Glencore (OTC: GLNCY) and Rio Tinto (NYSE: RIO). Reports indicate that Glencore initiated discussions with Rio Tinto about a possible merger to consolidate their substantial copper operations. However, these discussions have encountered...

Continue Reading
TD Bank’s Strategic Shift: Embracing 2025 with Reforms

Updated Category News Views 1229

TD Bank got slapped hard in 2024 when it became the largest bank ever to plead guilty to breaching the Bank Secrecy Act, racking up a $3 billion penalty. Yeah, you heard that right. This ain't just some slap on the wrist—this was a wake-up call, and desks across Wall Street were buzzing about what this meant for the bank's future. TD’s Penalty Hangover: What It Means...

Continue Reading
Gulfport Energy Secures $650 Million in Senior Notes for Growth

Updated Category News Views 60

Gulfport Energy Raises $650 Million Through Senior Notes Gulfport Energy (OTC: GPORQ) Corporation (NYSE: GPOR) has successfully completed a major private placement of senior notes, bringing in $650 million through the issuance of 6.750% Senior Notes that are due in 2029. This move, which was announced in a recent SEC filing, is intended to bolster the company's capital...

Continue Reading
CeriBell, Inc. Prepares for Healthcare Conference Engagement

Updated Category News Views 118

CeriBell's Upcoming Healthcare Conference Presentation CeriBell, Inc. (NASDAQ: CBLL), renowned for its innovative medical technology, is gearing up to present at an esteemed healthcare conference. The CEO and Co-founder, Jane Chao, Ph.D., will take the stage to provide valuable insights into the company’s advancements in EEG technology that focus on serious neurological...

Continue Reading
Top Stocks to Monitor This Week: Constellation and More

Updated Category News Views 282

Stocks to Keep an Eye on as the Week Begins As we step into a new week, investors and market watchers are eager to see what developments might unfold. With U.S. stock futures showing a positive trend, here are some noteworthy stocks that could capture the attention of investors today. Constellation Brands Inc.: Earnings on the Horizon Analysts anticipate that...

Continue Reading